Product NDC: | 0037-0113 |
Proprietary Name: | Butisol Sodium |
Non Proprietary Name: | Butabarbital Sodium |
Active Ingredient(s): | 30 mg/1 & nbsp; Butabarbital Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0037-0113 |
Labeler Name: | Meda Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA000793 |
Marketing Category: | NDA |
Start Marketing Date: | 19390801 |
Package NDC: | 0037-0113-60 |
Package Description: | 100 TABLET in 1 BOTTLE (0037-0113-60) |
NDC Code | 0037-0113-60 |
Proprietary Name | Butisol Sodium |
Package Description | 100 TABLET in 1 BOTTLE (0037-0113-60) |
Product NDC | 0037-0113 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Butabarbital Sodium |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19390801 |
Marketing Category Name | NDA |
Labeler Name | Meda Pharmaceuticals Inc. |
Substance Name | BUTABARBITAL SODIUM |
Strength Number | 30 |
Strength Unit | mg/1 |
Pharmaceutical Classes |